Cargando…
Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination
BACKGROUND: Antigen-specific anti-tumor vaccines have demonstrated clinical efficacy, but immunological and clinical responses appear to be patient-dependent. We hypothesized that naturally-occurring differences in amino acid sequence of a host’s target antigen might predict for immunological outcom...
Autores principales: | Becker, Jordan T, McNeel, Douglas G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986973/ https://www.ncbi.nlm.nih.gov/pubmed/24764533 http://dx.doi.org/10.1186/2051-1426-1-2 |
Ejemplares similares
-
B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines
por: Colluru, Viswa Teja, et al.
Publicado: (2016) -
IgG Responses to Tissue-Associated Antigens as Biomarkers of Immunological Treatment Efficacy
por: Smith, Heath A., et al.
Publicado: (2011) -
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination
por: Johnson, Laura E., et al.
Publicado: (2017) -
B lymphocyte mediated antigen presentation of plasmid DNA
por: Colluru, Viswa Teja, et al.
Publicado: (2013) -
The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
por: Smith, Heath A., et al.
Publicado: (2010)